AI Risk in Corporate Filings: The Consequences for Healthcare, Insurance, and Financial Services
Regulated industries across Canada and the UK are now exposed to severe risks due to misstated AI capability in corporate filings, as identified by regulators in recent reports. These companies face significant potential liabilities if they fail to disclose accurate information about their AI capabilities.
Misstated AI capability in corporate filings poses three major risks for healthcare, insurance, and financial services organizations: capability risk (does the technology do what was claimed), governance risk (can the decision be defended when boards or regulators ask), and liability risk (what the organization is accountable for when the AI errs). Companies that buy or deploy AI systems without accurate information about their capabilities are vulnerable to these risks.
To protect themselves, prudent organizations must take strategic and compliance steps. First, they should conduct a thorough review of their current AI capabilities and disclose any inaccuracies in corporate filings. Second, they must assess the potential consequences of inaccurate disclosures on their reputation, governance, and liability exposure. Finally, they should implement measures to prevent similar errors from occurring in the future.
Independent validation by firms like Straven & Co can help organizations address these risks more effectively. By examining AI decisions against an organization’s operations, its people, its governance and legal exposure, and the vendor’s actual claims, Straven delivers a plain verdict: proceed, proceed with conditions, or do not. This independence is essential in ensuring that the validation process remains unbiased and trustworthy.
Straven & Co examines AI decisions before they are acted on at https://stravenandco.com.